← Back to Search

Behavioural Intervention

At-home tDCS for Autism

Phase 2
Recruiting
Research Sponsored by Holland Bloorview Kids Rehabilitation Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Children with a diagnosis of autism spectrum disorder and self-regulation impairment or social communication challenges
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0 weeks, 6 weeks, 18 weeks
Awards & highlights

Study Summary

This trial explores if a safe, non-invasive brain stimulation can help improve social communication and self-regulation in youth with Autism Spectrum Disorder.

Who is the study for?
This trial is for children with Autism Spectrum Disorder (ASD) who have difficulties with self-regulation or social communication. They must be able to participate in at-home brain stimulation treatments.Check my eligibility
What is being tested?
The study tests if a home-based brain stimulation technique, called tDCS, can help improve social communication and behavior in kids with ASD. Participants are randomly assigned to either the real tDCS or a sham (fake) treatment for three weeks.See study design
What are the potential side effects?
tDCS is generally safe and tolerable. Possible side effects may include mild discomfort at the site of stimulation, itching, tingling during the application, headache, fatigue, and nausea.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My child has autism with difficulties in self-regulation or social communication.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0 weeks, 6 weeks, 18 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 0 weeks, 6 weeks, 18 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adherence
Attrition
Blinding
+1 more
Secondary outcome measures
Inhibitory control
Magnetic Resonance Imaging (MRI)
Overall Clinical Change

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: tDCSExperimental Treatment1 Intervention
active tDCS
Group II: ShamPlacebo Group1 Intervention
sham tDCS

Find a Location

Who is running the clinical trial?

Holland Bloorview Kids Rehabilitation HospitalLead Sponsor
67 Previous Clinical Trials
14,047 Total Patients Enrolled
23 Trials studying Autism Spectrum Disorder
8,841 Patients Enrolled for Autism Spectrum Disorder
~13 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top